Kevin Gao

16 posts

Kevin Gao

Kevin Gao

@XGaoKevin

Ph.D candidate in Molecular Pharmacology and Experimental Therapeutics at #MayoClinic. Sudden death genomics I Cardiac channelopathies

Katılım Mayıs 2021
99 Takip Edilen65 Takipçiler
Kevin Gao retweetledi
Michael J. Ackerman MD,PhD
Michael J. Ackerman MD,PhD@MJAckermanMDPhD·
In the life of a mentor, this past wk was unforgettable. 3 of my PhD students: ⁦@XGaoKevin⁩ ⁦@GarmanyRamin⁩ & ⁦@sahejbains⁩ successfully defended their PhD thesis. I started as their adviser, grew into their mentor, and became their “father”. So PROUD of them!
Michael J. Ackerman MD,PhD tweet mediaMichael J. Ackerman MD,PhD tweet media
English
2
6
42
4.8K
Kevin Gao retweetledi
John Giudicessi MD, PhD
John Giudicessi MD, PhD@JohnGiudicessi·
Strong work by @XGaoKevin presenting on how BrS, LQT3 and MEPPC-causative variants have distinct 3D clustering patterns @ #HRS2023! Potential new tool in the battle to interpret SCN5A VUS?
English
1
2
12
838
Michael J. Ackerman MD,PhD
Michael J. Ackerman MD,PhD@MJAckermanMDPhD·
Thanks @hrs_journal & congrats to my @MayoGradSchool PhD student @XGaoKevin on his characterization of a lidocaine/mexiletine-insensitive LQT3-causative mutation. Unfortunately, we were unable to become smart enough soon enough for the beautiful girl who owned this variant.
Michael J. Ackerman MD,PhD tweet media
HeartRhythm@hrs_journal

Functional Characterization and Identification of a Therapeutic for a Novel SCN5A-F1760C Variant Causing Type 3 Long QT Syndrome Refractory to All Guideline-Directed Therapies, by @MJAckermanMDPhD and colleagues heartrhythmjournal.com/article/S1547-…

English
1
5
13
2.1K
Kevin Gao
Kevin Gao@XGaoKevin·
Excited to share our latest work in @hrs_journal on characterization of a novel SCN5A variant causing LQT3. Phenytoin could be effective as a variant specific therapy. Thanks @MJAckermanMDPhD for the mentorship!
HeartRhythm@hrs_journal

Functional Characterization and Identification of a Therapeutic for a Novel SCN5A-F1760C Variant Causing Type 3 Long QT Syndrome Refractory to All Guideline-Directed Therapies, by @MJAckermanMDPhD and colleagues heartrhythmjournal.com/article/S1547-…

English
2
1
6
853
Kevin Gao
Kevin Gao@XGaoKevin·
Very excited to share my work on iPSC-CM modeling for MEPPC at #AHA22 Grateful to have the opportunity to work under the mentorship of @MJAckermanMDPhD @JohnGiudicessi and the amazing team at @MayoClinicWSRGH
Michael J. Ackerman MD,PhD@MJAckermanMDPhD

Very fortunate to have @XGaoKevin on my team. Kevin is a PhD student @MayoGradSchool and just finished is first ever presentation @AHAMeetings. The model system that he has developed for Multifocal Ectopic Purkinje-Related PVCs is really cool. Great work Kevin.

English
0
0
5
0
Kevin Gao retweetledi
Michael J. Ackerman MD,PhD
Michael J. Ackerman MD,PhD@MJAckermanMDPhD·
Very fortunate to have @XGaoKevin on my team. Kevin is a PhD student @MayoGradSchool and just finished is first ever presentation @AHAMeetings. The model system that he has developed for Multifocal Ectopic Purkinje-Related PVCs is really cool. Great work Kevin.
Michael J. Ackerman MD,PhD tweet media
Chicago, IL 🇺🇸 English
0
4
14
0
Michael J. Ackerman MD,PhD
Michael J. Ackerman MD,PhD@MJAckermanMDPhD·
Hey @Starbucks-say it isn’t so! Just heard that the 1 in the Kahler Grand Hotel just across from @MayoClinic is closing. Patients love it, staff loves it. Their baristas R the best. If true, change your mind immediately. Or as the gr8 @RandyMoss on @ESPN would say, “Come On Man!”
Michael J. Ackerman MD,PhD tweet media
English
5
0
12
0
Kevin Gao retweetledi
Michael J. Ackerman MD,PhD
Michael J. Ackerman MD,PhD@MJAckermanMDPhD·
CONGRATS ⁦@XGaoKevin⁩ on his first poster presentation at #HRS2021 detailing effect of #mexiletine on 3 different #LQTS re-engineered #heart cell models from pts w/ LQT1, LQT2, & LQT3. This Rx is not for just LQT3 anymore. At bench & at bedside, remember it for tough LQT2.
Michael J. Ackerman MD,PhD tweet media
English
0
1
16
0